Stockscreener 앱 받기
6.705
0.81%
-0.055
전일 마감가:
$6.76
열려 있는:
$6.75
하루 거래량:
61,020
Relative Volume:
0.15
시가총액:
$448.51M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-11.18
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
-0.07%
1개월 성능:
-7.77%
6개월 성능:
-15.66%
1년 성능:
-41.54%
1일 변동 폭
$6.67
$6.765
1주일 범위
$6.59
$7.14
52주 변동 폭
$5.81
$14.38
Bioventus Inc Stock (BVS) Company Profile
명칭
Bioventus Inc
전화
(919) 474-6700
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.705 | 452.19M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
133.24 | 233.69B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.41 | 143.42B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
371.41 | 143.48B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.17 | 125.54B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.15 | 44.47B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-07 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2022-11-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-11-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 개시 | Craig Hallum | Buy |
| 2021-11-15 | 재개 | Morgan Stanley | Overweight |
| 2021-11-10 | 재개 | JP Morgan | Overweight |
| 2021-07-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-08 | 개시 | Canaccord Genuity | Buy |
| 2021-03-08 | 개시 | Goldman | Buy |
| 2021-03-08 | 개시 | JP Morgan | Overweight |
| 2021-03-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioventus Inc 주식(BVS)의 최신 뉴스
What technical models suggest about Bioventus Inc.’s comebackJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Full technical analysis of Bioventus Inc. stockMarket Performance Recap & Real-Time Volume Trigger Notifications - newser.com
Bioventus Inc. stock retracement – recovery analysisJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Is Bioventus Inc a good long term investmentSwing Trading Ideas & Rapid Capital Gain - earlytimes.in
Multi factor analysis applied to Bioventus Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - newser.com
Volatility clustering patterns for Bioventus Inc.Quarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Can Bioventus Inc. hit a new high this monthPortfolio Value Report & Technical Pattern Alert System - newser.com
How Bioventus Inc. stock benefits from strong dollarPortfolio Update Summary & Reliable Intraday Trade Plans - newser.com
Using Bollinger Bands to evaluate Bioventus Inc.Trade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Forecasting Bioventus Inc. price range with options data2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Bioventus Inc Stock Analysis and ForecastBear Market Strategies & In-Depth Analyst Ratings Explained Simply - earlytimes.in
What drives Bioventus Inc stock priceBreakout Stock Watch & Small Investment Portfolio Growth - earlytimes.in
PetVivo (NASDAQ:PETV) versus Bioventus (NYSE:BVS) Head-To-Head Comparison - Defense World
Comparing Bioventus Inc. in custom built stock radarsProduct Launch & Fast Entry Momentum Alerts - newser.com
Comparing Bioventus (NYSE:BVS) and Retractable Technologies (NYSE:RVP) - Defense World
Orthobiologics Market May See a Big Move | Major Giants Medtronic, Zimmer Biomet, Bioventus - newstrail.com
Is Bioventus Inc. building a consolidation baseTreasury Yields & Weekly Chart Analysis and Trade Guides - newser.com
Bioventus (NYSE:BVS) Shares Gap DownHere's What Happened - MarketBeat
Bioventus Inc. stock daily chart insightsBull Run & Technical Pattern Recognition Alerts - newser.com
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating - 富途牛牛
Should You Be Worried About Bioventus Inc.'s (NASDAQ:BVS) 1.3% Return On Equity? - Yahoo Finance
Goldman Sachs Group Inc. Raises Stake in Bioventus Inc. $BVS - Defense World
Aug Closing: What is Bioventus Inc.’s TAM (Total Addressable Market)July 2025 EndofMonth & Fast Momentum Stock Entry Tips - خودرو بانک
Combining price and volume data for Bioventus Inc.Wall Street Watch & Technical Entry and Exit Alerts - newser.com
Does Bioventus Inc. show high probability of rebound2025 Market Trends & Long-Term Growth Stock Strategies - newser.com
Aug Catalysts: Does Bioventus Inc offer margin of safetyQuarterly Growth Report & Long Hold Capital Preservation Plans - khodrobank.com
Bioventus Inc (BVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.88%
0.93%
자본화:
|
볼륨(24시간):